secwatch.observer — SEC 8-K summary
======================================

Issuer:     RESMED INC (RMD)
CIK:        0000943819
Form:       8-K
Filed at:   2022-04-28T23:59:59+00:00
Accession:  0001193125-22-127535
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ResMed Q3 revenue up 12% to $864.5M; non-GAAP EPS $1.32, up 2% YoY
------------------------------------------------------------------

- Revenue $864.5M (+12% YoY); constant currency growth 14%.
- GAAP diluted EPS $1.22 (up from loss of $0.54); non-GAAP diluted EPS $1.32 (+2%).
- Gross margin contracted 140 bps to 56.8%; non-GAAP gross margin contracted 150 bps to 58.1%.
- Board declared $0.42/share dividend, record May 12, payable June 16, 2022.
- CEO cites strong sleep/respiratory demand but supply chain disruptions limit ability to meet demand.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/943819/000119312522127535/0001193125-22-127535-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/943819/000119312522127535/d319859d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-127535

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer